Vitrolife’s Steen Solution wins Australian approval

Vitrolife’s product Steen Solution is part of a new method for functional testing and preservation of lungs outside the body. The technology makes it possible for the first time to test the function of donated lungs outside the body by pumping Steen Solution into the organ’s system of vessels before possible use.

According to the company, the number of potential organs that can be transplanted increases considerably with the Steen Solution method. Steen Solution has already been approved for sales in Europe.

Magnus Nilsson, CEO of Vitrolife, said: “It is a great success for Vitrolife that this unique product has now been approved by the Australian authorities.”